A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-Oestrogen Therapy Delayed Until After Radiotherapy.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 13 Jul 2017
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms STARS
- 24 Jan 2017 Status changed from recruiting to active, no longer recruiting.
- 16 May 2013 Planned end date changed from 1 May 2015 to 1 Dec 2024 as reported by ClinicalTrials.gov.
- 08 Jul 2011 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry.